Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of mainte (Q85404993)
Jump to navigation
Jump to search
scientific article published on 02 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of mainte |
scientific article published on 02 November 2012 |
Statements
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance (English)
Maurizio Brausi
Richard Sylvester
Aldo Bono
Cees van de Beek
George van Andel
Wolfgang Hoeltl
Levent Turkeri
Sandrine Marreaud
Sandra Collette
Willem Oosterlinck
2 November 2012